
JuveXO Pro
Professional-line exosome formulations offered in two presentations. Use according to manufacturer instructions.
Advanced UCMSC-Derived Exosomes & Secretome Technology
Discover JuveXO Exosomes, a portfolio of cell-derived extracellular vesicles and secretome-based formulations developed for professional applications. At the foundation of JuveXO technology are Umbilical Cord Lining Mesenchymal Stem Cells (UCMSCs), a distinctive cell source associated with more than a decade of scientific research and proprietary development.
What makes JuveXO different?
JuveXO begins with Umbilical Cord Lining Mesenchymal Stem Cells (UCMSCs), sourced from the lining of the umbilical cord. The manufacturer describes more than a decade of research and proprietary development behind its work with UCMSCs.
From these cells come exosomes and the broader secretome, produced using ExoCM®, the manufacturer's proprietary technology. These cell-derived materials form the basis of the JuveXO portfolio.

Artistic rendering of exosome release from a stem cell
The science
Exosomes are a subset of extracellular vesicles studied for their role in cellular communication. The secretome is broader: it includes extracellular vesicles together with soluble proteins and signaling factors released by cells.
Cell-derived components
UCMSC-derived exosomes and secretome materials produced with ExoCM®.
Added cosmetic ingredients
Hyaluronic acid, collagen I/III, biotin, glutathione, niacinamide and formulation-specific proteins, depending on the product.
Research context
RESTEM investigates living UCMSC therapies in clinical research. This work reflects broader scientific interest in UCMSCs as a cell source. It does not involve finished JuveXO Exosomes, does not confer FDA approval and does not establish the safety or efficacy of any JuveXO product.
Visit RESTEMThe portfolio

Professional-line exosome formulations offered in two presentations. Use according to manufacturer instructions.

A topical cosmetic formulation with hyaluronic acid, collagen I/III, biotin, glutathione and niacinamide.

A scalp-focused topical cosmetic formulation with hyaluronic acid, collagen I/III, biotin and manufacturer-described proprietary proteins.
Product images courtesy of JuveXO.
At a glance
Cosmetic products positioned by the manufacturer for topical use.
Dedicated formulations for skin and scalp care routines.
Multidose presentations applied per manufacturer instructions.
Cell-derived components combined with selected cosmetic ingredients.
HA, collagen I/III, biotin and formulation-specific additions.
Built on the manufacturer's UCMSC and ExoCM® platform.
For practices
Professional cosmetic products that extend a practice's skin and scalp care conversations.
Presentations designed for use per manufacturer instructions, supporting planning around handling and use.
Evaluate how the products fit existing treatment rooms, staff routines and stock management.
Access to manufacturer-supplied education so teams can discuss the technology accurately.
Partnership terms are reviewed directly with JJV Bio. No return on investment is implied or guaranteed.
Support
Manufacturer product information and specification documents.
Storage and handling as directed by the manufacturer.
Background on extracellular vesicles, the secretome and UCMSCs.
Educational sessions as made available by the manufacturer and JJV Bio.
FAQ
Exosomes are a subset of extracellular vesicles: small, membrane-bound particles released by cells and studied in research for their role in cellular communication.
The secretome is the collection of materials a cell releases, including extracellular vesicles as well as soluble proteins and signaling factors.
Umbilical Cord Lining Mesenchymal Stem Cells (UCMSCs) are mesenchymal stem cells sourced from the lining of the umbilical cord. They are the cell source underlying JuveXO technology.
ExoCM® is the manufacturer's proprietary technology for producing its UCMSC-derived exosome and secretome materials. Technical details are available from the manufacturer.
RESTEM is a company that investigates living UCMSC therapies in clinical research. JuveXO shares a foundation in UCMSC science; product-specific details of the relationship should be confirmed with the manufacturer.
No such claim is made here. RESTEM's clinical research concerns living UCMSC therapies, not finished JuveXO cosmetic products, and it does not establish the safety or efficacy of JuveXO Exosomes.
No FDA approval or clearance is claimed. Product-specific intended use and regulatory status should be confirmed with the manufacturer before any use or marketing.
The portfolio includes the Pro Line (50B/1mL and 250B/5mL) and the Aesthetics Line: Skin (50B/5mL) and Hair (50B/5mL).
Skin combines UCMSC-derived components with hyaluronic acid, collagen I/III, biotin, glutathione and niacinamide. Hair combines them with hyaluronic acid, collagen I/III, biotin and manufacturer-described proprietary proteins.
Storage and handling are governed by the manufacturer's instructions supplied with each product.
Schedule a consultation with JJV Bio to review the portfolio, education resources and commercial considerations.
Explore the science. Discover the portfolio.
JJV Bio is a strategic commercialization partner for JuveXO, not its manufacturer. Schedule a consultation to review the portfolio and education resources.
For professional education and commercial inquiries. Product-specific intended uses and regulatory status should be confirmed with the manufacturer. JuveXO's own cosmetic products are positioned for topical use only, not for injection, IV or therapeutic use.
Regulatory note. Products in this portfolio do not share a single regulatory status, and some are not FDA-approved or cleared. Product-specific regulatory information must be reviewed before any marketing use. Nothing on this site is a claim of safety, efficacy, or suitability for any indication.